Cidara Therapeutics, Inc. — Director's Dealing 2016

Jul 5, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cidara Therapeutics, Inc. (CDTX)
CIK: 0001610618
Period of Report: 2016-07-01

Reporting Person: Abdollahian Neil (Chief Business Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-01	Stock Option (right to buy)	$10.45	A	100000	Acquired	2026-06-30	Common Stock (100000)	Direct

Footnotes

F1: 25% of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date of July 1, 2016; 1/48th of the shares subject to the option shall vest monthly thereafter, such that all shares will be vested on July 1, 2020.